Antibiotics, Vol. 9, Pages 230: Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study

Antibiotics, Vol. 9, Pages 230: Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study Antibiotics doi: 10.3390/antibiotics9050230 Authors: Harada Shimizu Kawaguchi Furuhashi Ishihara Fosfomycin is a candidate drug for extended-spectrum β-lactamase (ESBL)-producing bacteria, but its efficacy is yet to be investigated in dogs. This study investigated...

Antibiotics

03:00

Antibiotics, Vol. 9, Pages 229: Omics for Bioprospecting and Drug Discovery from Bacteria and Microalgae

Antibiotics, Vol. 9, Pages 229: Omics for Bioprospecting and Drug Discovery from Bacteria and Microalgae Antibiotics doi: 10.3390/antibiotics9050229 Authors: Reuben Maghembe Donath Damian Abdalah Makaranga Stephen Samwel Nyandoro Sylvester Leonard Lyantagaye Souvik Kusari Rajni Hatti-Kaul “Omics” represent a combinatorial approach to high-throughput analysis of biological entities for various purposes. It broadly encompasses genomics, transcriptomics,...

Antibiotics

Mon May 04, 2020 03:00

Σήμανση της παραπάνω ενότητας ως αναγνωσμένης